Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 9004687

Promoting client satisfaction.

M Taccetta-Chapnick·G Rafferty
View original source ↗Export metadata ↓

Abstract

Traditionally; the client has been seen as a patient with needs rather than a consumer with options. Analyzing the perception of the client as well as the health care team leads to high standards of cost-effective, quality patient care. Client satisfaction is the key to future referrals and hospital revenues.

Explore related subjects

Cost-Benefit AnalysisHumansMarketing of Health ServicesPatient AdvocacyPatient SatisfactionPatient-Centered CareQuality of Health CareJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M Taccetta-Chapnick, G Rafferty. 1997. Promoting client satisfaction.. https://pubmed.ncbi.nlm.nih.gov/9004687/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1998

[Concept of stress ulcer prevention. Is re-thinking necessary?].

BACKGROUND: The efficiency of stress ulcer prophylaxis in the prevention of gastrointestinal bleeding in critically ill patients has led to its widespread use. The lower incidence of stress ulcer bleeding, the side-effects and the cost of the prophylaxis have made it necessary targeting this preventive therapy to those patients most likely to benefit. Metaanalysis of studies on patients who received no stress ulcer prophylaxis showed few critically ill patients with important gastrointestinal bleeding. INDICATIONS: Patients who benefit most from receiving stress ulcer prophylaxis are critically ill patients with coagulopathy, or those requiring mechanical ventilation for more than two days. In patients with headinjuries, widespread burns or severe hypotension, the effects of stress ulcer prophylaxis have not been fully researched, but we would recommend administering stress ulcer prophylaxis in these cases. TREATMENT: Following a recent metaanalysis, stress ulcer prophylaxis is performed either with H2-blockers (ranitidine, famotidine) or sucralfate.

Cost-Benefit Analysis↗